Director, Neurobiology - Target Validation and Drug Discovery at Valo Health

Lexington, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

PhD in Biological Sciences or related field with 10+ years of experience (including postdoctoral), MS with 14+ years, or BS with 16+ years, and deep expertise in Parkinson’s disease, human cell assay/model development, and immunology/neuroinflammation
Expertise in in vitro systems including cell culture, molecular biology, genetic manipulation, and development of functional assays
Experience leading early and established preclinical stage drug discovery programs
Experience managing and collaborating with teams and scientists in a matrixed fashion to produce high-quality data
Track record of impactful scientific contributions demonstrated by high impact publications and prior success in progressing programs through a therapeutic pipeline
Strong oral and written communication, presentation, and interpersonal skills
Permanent U.S. work authorization without need for immediate or future sponsorship

Responsibilities

Develop strategies and validation platforms to validate novel targets
Serve as research project lead on various stage preclinical drug discovery projects
Lead and mentor a team of scientists dedicated to cell model development for target validation and support of biology goals in drug discovery programs
Serve as subject matter expert in Parkinson’s disease and other neurodegenerative diseases mechanisms involved in immune and other CNS-relevant cell type dysregulation
Provide thought leadership and guidance on CNS disease-relevant assays, staying abreast of emerging trends and advancements
Generate hypothesis-driven experimental plans and proposals for target validation in collaboration with data scientists and other experts to enable decision making
Manage scientists (direct reports) and teams in a matrixed manner to ensure high-quality data generation and timely delivery of key readouts
Design experiments to coordinate and manage with CROs
Collaborate with Valo’s tissue and cell model experts to support target validation and ongoing drug discovery projects

Skills

Neurobiology

Target Validation

Drug Discovery

Cell Model Development

Parkinson's Disease

Neurodegenerative Diseases

CNS Assays

Preclinical Research

Team Leadership

Hypothesis-Driven Research

Assay Development

Valo Health

Drug discovery using machine learning technology

About Valo Health

Valo Health focuses on drug discovery and development in the biopharmaceutical sector, utilizing advanced technology to create new drugs and therapies. The company employs its proprietary Opal Computational platform, which integrates machine learning, tissue biology, and patient data to streamline the drug discovery process. This platform allows Valo Health to identify potential drug candidates more quickly and accurately than traditional methods. Valo Health differentiates itself from competitors by combining technology with life sciences, fostering a collaborative culture that addresses significant challenges in drug development. The company's goal is to improve health outcomes for patients worldwide by delivering effective solutions through partnerships with pharmaceutical companies and research institutions.

Boston, MassachusettsHeadquarters

2019Year Founded

$474.2MTotal Funding

LATE_VCCompany Stage

AI & Machine Learning, BiotechnologyIndustries

51-200Employees

Risks

Leadership changes may impact Valo's strategic direction and decision-making.

Heavy reliance on Novo Nordisk partnership poses financial risks if expectations aren't met.

Intensifying competition in AI-driven drug discovery could challenge Valo's market position.

Differentiation

Valo Health integrates AI and human-centric data for drug discovery and development.

The Opal Computational Platform offers an end-to-end solution for drug discovery.

Valo's approach combines machine learning, tissue biology, and patient data for precision therapeutics.

Upsides

Valo's partnership with Novo Nordisk could yield up to $4.6 billion in milestone payments.

The growing market for AI-driven drug discovery platforms supports Valo's business model.

Strategic partnerships with pharmaceutical companies enhance Valo's revenue and market reach.

Land your dream remote job 3x faster with AI

Try Jobo Free